[Neurochemical aspects of the pharmacology of GABAergic substances].
D000625:Aminooxyacetic Acid / Q000494:pharmacology; D000818:Animals; D000927:Anticonvulsants; D001418:Baclofen / Q000494:pharmacology; D001640:Bicuculline / Q000494:pharmacology; D001923:Brain Chemistry; D051379:Mice; D009118:Muscimol / Q000494:pharmacology; D009557:Nipecotic Acids / Q000494:pharmacology; D010205:Pantothenic Acid / Q000031:analogs & derivatives / Q000494:pharmacology; D010889:Piracetam / Q000494:pharmacology; D012978:Sodium Oxybate / Q000494:pharmacology; D009435:Synaptic Transmission; D014635:Valproic Acid / Q000494:pharmacology; D005680:gamma-Aminobutyric Acid / Q000031:analogs & derivatives / Q000494:pharmacology / Q000502:physiology*
D000927:Anticonvulsants; D009557:Nipecotic Acids; D000625:Aminooxyacetic Acid; C016030:pantogab; D010205:Pantothenic Acid; C004480:4-amino-3-hydroxybutyric acid; D009118:Muscimol; D005680:gamma-Aminobutyric Acid; D014635:Valproic Acid; D012978:Sodium Oxybate; D001418:Baclofen; C008842:4-amino-3-phenylbutyric acid; D001640:Bicuculline; D010889:Piracetam
Neĭrokhimicheskie aspekty farmakologii GAMK-ergicheskikh veshchestv.